Skip to main content

Table 1 Clinical and preanalytical characteristics of 30 patients

From: Inter-assay variability of next-generation sequencing-based gene panels

Group No Age Sex Cancer type Histology Stage Concentration of library DNA (nM) Q-value
FF 1 45 M Pancreas Adenocarcinoma IV 8.2 0.85
2 57 M Colorectal Adenocarcinoma IV 16.2 0.82
3 56 F CUP Adenocarcinoma IV 18.0 1.00
4 52 M Biliary tract Adenocarcinoma IV 14.4 0.60
5 56 M Pancreas Adenocarcinoma IV 13.0 0.79
6 72 M Colorectal Adenocarcinoma IV 18.5 0.72
7 82 M Pancreas Adenocarcinoma IV 5.8 0.85
8 55 F Esophagus Squamous cell carcinoma IV 30.7 1.43
9 61 F Pancreas Neuroendocrine tumor IV 21.9 1.23
10 58 F Biliary tract Adenocarcinoma IV 25.1 0.89
FFPE-H 11 47 F Pancreas Adenocarcinoma IV 13.2 1.32
12 62 F CUP Adenocarcinoma IV 28.5 0.29
13 72 F CUP Squamous cell carcinoma IV 36.9 0.20
14 69 M CUP Adenocarcinoma IV 12.1 0.36
15 64 F NSCLC Adenocarcinoma IV 12.8 0.23
16 65 F Gastric Adenocarcinoma IV 7.4 1.06
17 73 M NSCLC Adenocarcinoma IV 4.9 0.43
18 57 F Pancreas Adenocarcinoma IV 8.1 0.26
19 73 M Esophagus Squamous cell carcinoma IV 8.2 0.36
20 69 F Sarcoma Leiomyosarcoma IV 6.1 0.44
FFPE-L 21 36 F NSCLC Adenocarcinoma IV 3.4 0.22
22 39 F Colorectal Adenocarcinoma IV 1.0 0.21
23 64 F Breast Adenocarcinoma IV 1.0 0.44
24 57 M Esophagus Squamous cell carcinoma IV 1.6 0.14
25 52 F Biliary tract Adenocarcinoma IV 0.2 0.11
26 61 F Pancreas Adenocarcinoma IV 2.3 0.29
27 68 M Biliary tract Adenocarcinoma IV 4.2 0.57
28 66 M Colorectal Adenocarcinoma IV 1.4 0.07
29 65 M Gastric Adenocarcinoma IV 1.8 0.34
30 73 M Bladder Urothelial carcinoma IV 4.0 0.27
  1. M male, F female, CUP cancer of unknown primary, NSCLC non-small cell lung cancer